Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -8.84%99.51M | -9.04%109.17M | -5.78%120.01M | -0.23%127.38M | -14.93%127.67M | -14.64%150.08M | -14.41%175.81M | -16.80%205.42M | -12.68%246.91M | -10.81%282.75M |
| Revenue from customers | -8.84%99.51M | -9.04%109.17M | -5.78%120.01M | 1.85%127.38M | -16.66%125.07M | -14.64%150.08M | -14.41%175.81M | -16.80%205.42M | -12.68%246.91M | -10.81%282.75M |
| Income from government grants | ---- | ---- | --2K | ---- | --2.61M | ---- | ---- | ---- | ---- | ---- |
| Cash paid | 8.36%-91.95M | 10.35%-100.33M | 6.52%-111.92M | -0.98%-119.72M | 12.92%-118.55M | 18.21%-136.15M | 11.42%-166.46M | 19.40%-187.92M | 12.31%-233.14M | 11.31%-265.86M |
| Payments to suppliers for goods and services | 8.36%-91.95M | 10.35%-100.33M | 6.52%-111.92M | -0.98%-119.72M | 12.92%-118.55M | 18.21%-136.15M | 11.42%-166.46M | 19.40%-187.92M | 12.31%-233.14M | 11.31%-265.86M |
| Direct interest paid | 57.83%-70K | 44.11%-166K | -59.68%-297K | 14.29%-186K | 59.67%-217K | -72.44%-538K | 0.95%-312K | -52.91%-315K | -100.00%-206K | 45.21%-103K |
| Direct interest received | 83.54%145K | 1,480.00%79K | --5K | ---- | -95.24%1K | 31.25%21K | 45.45%16K | 120.00%11K | -28.57%5K | -58.82%7K |
| Direct tax refund paid | 7.46%-5.66M | 15.89%-6.11M | 11.94%-7.27M | -0.22%-8.25M | 6.71%-8.23M | 14.20%-8.83M | 21.32%-10.29M | 1.89%-13.08M | 18.02%-13.33M | 10.26%-16.26M |
| Operating cash flow | -24.59%1.99M | 390.69%2.64M | 168.93%537K | -216.27%-779K | -85.37%670K | 471.83%4.58M | -129.92%-1.23M | 1,622.59%4.12M | -55.74%239K | 152.99%540K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -3,600.00%-70K | 166.67%2K | 94.83%-3K | -1,350.00%-58K | 76.47%-4K | 94.46%-17K | 43.67%-307K | 46.78%-545K | 28.04%-1.02M | -42.59%-1.42M |
| Net PPE purchase and sale | -3,600.00%-70K | 166.67%2K | 94.83%-3K | -1,350.00%-58K | -100.57%-4K | 350.36%701K | 11.11%-280K | 60.58%-315K | 42.72%-799K | -152.26%-1.4M |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | 88.26%-27K | -2.22%-230K | -703.57%-225K | 93.71%-28K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---718K | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | --741K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -3,600.00%-70K | 166.67%2K | 94.83%-3K | -1,350.00%-58K | 76.47%-4K | 94.46%-17K | 43.67%-307K | 46.78%-545K | 28.04%-1.02M | -42.59%-1.42M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -156.23%-695K | 283.38%1.24M | -159.17%-674K | 215.05%1.14M | 81.96%-990K | -5.49M | ||||
| Net issuance payments of debt | 99.90%-2K | -542.95%-2.01M | -120.30%-312K | 480.45%1.54M | 91.24%-404K | ---4.61M | ---- | ---- | ---- | ---- |
| Net common stock issuance | -96.94%109K | --3.56M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash dividends paid | ---572K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | 64.29%-230K | 11.05%-644K | 9.05%-724K | 32.08%-796K | 33.18%-1.17M | ---1.75M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -156.23%-695K | 283.38%1.24M | -159.17%-674K | 215.05%1.14M | 81.96%-990K | ---5.49M | ---- | ---- | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 1,652.56%4.1M | -36.24%234K | 321.84%367K | -78.68%87K | -68.30%408K | -53.74%1.29M | 289.90%2.78M | -262.62%-1.47M | -163.32%-404K | -74.48%638K |
| Current changes in cash | -68.45%1.22M | 2,866.43%3.87M | -146.36%-140K | 193.21%302K | 64.94%-324K | 39.96%-924K | -143.09%-1.54M | 555.03%3.57M | 11.10%-785K | 56.22%-883K |
| Effect of exchange rate changes | 66.67%-2K | -185.71%-6K | 131.82%7K | -833.33%-22K | -93.33%3K | 2.27%45K | -6.38%44K | 117.03%47K | -73.58%-276K | -202.58%-159K |
| End cash Position | 29.75%5.32M | 1,652.56%4.1M | -36.24%234K | 321.84%367K | -78.68%87K | -68.30%408K | -40.25%1.29M | 247.03%2.15M | -262.62%-1.47M | -163.32%-404K |
| Free cash from | -27.29%1.92M | 393.45%2.64M | 163.80%534K | -225.68%-837K | -85.33%666K | 395.06%4.54M | -143.09%-1.54M | 555.03%3.57M | 11.10%-785K | 56.22%-883K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |